Research output: Contribution to journal › Article › peer-review
Нарушения сна после COVID-19 у больных с первичными головными болями. / Тверитин, Е.А.; Коновалова, Д.А.; Хамзин, Д.В.; Чигарева, М.Л.; Сизикова, Елена Алексеевна; Дериглазова, Е.А.; Рязанова, А.Е.; Полуэктов, М.Г.; Гилёв, Д.В.; Лебедева, Е.Р.
In: ЖУРНАЛ НЕВРОЛОГИИ И ПСИХИАТРИИ ИМ. C.C. КОРСАКОВА, Vol. 125, No. 8, 29.08.2025, p. 127-132.Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - Нарушения сна после COVID-19 у больных с первичными головными болями
AU - Тверитин, Е.А.
AU - Коновалова, Д.А.
AU - Хамзин, Д.В.
AU - Чигарева, М.Л.
AU - Сизикова, Елена Алексеевна
AU - Дериглазова, Е.А.
AU - Рязанова, А.Е.
AU - Полуэктов, М.Г.
AU - Гилёв, Д.В.
AU - Лебедева, Е.Р.
PY - 2025/8/29
Y1 - 2025/8/29
N2 - Objective. To analyze the incidence of new-onset sleep disorders after novel coronavirus infection (COVID-19) in patients with primary headaches. Material and methods. A prospective case-control study was conducted from May 2022 to July 2024 using a semi-structured interview with 212 patients with primary headaches and complaints of sleep problems with a history of COVID-19 (main group, n=135 patients, 98% women, mean age 46.3 years) and without COVID-19 (control group, n=77, 54% women, mean age 45.7 years). COVID-19 was confirmed by a PCR test. Patients of both groups were included in the study in parallel according to the inclusion and exclusion criteria. The period from the onset of COVID-19 to the interview was ≥12 months in 57.7% of the patients, from 6 to 12 months in 20.1% of the patients, and up to 6 months in 22.2% of the patients. Most patients (87%) had mild symptoms of COVID-19. Results. Pre-existing sleep disorders (before the COVID-19 pandemic, before 2020) in patients with primary headaches were found in 56.3% of patients with a history of COVID-19 and 59.7% of patients without COVID-19. In 39 (28.8%) patients out of 135 patients with COVID-19, sleep disorders debuted for the first time at the onset of COVID-19 and persisted at the time of the interview (not less than 6 months): 25 patients (18.5%) had chronic insomnia, 5 patients (3.7%) restless legs syndrome, 7 people (5.2%) hypersomnia, 2 (1.5%) obstructive sleep apnea syndrome. In all these patients, sleep disturbances were not associated with anxiety, depression, other diseases, or medications, but were associated in close temporal relationship with COVID-19. Conclusion. Our study showed that a third of patients with primary headache disorders have new-onset sleep disorders associated with COVID-19 which persisted for a long time after recovery.
AB - Objective. To analyze the incidence of new-onset sleep disorders after novel coronavirus infection (COVID-19) in patients with primary headaches. Material and methods. A prospective case-control study was conducted from May 2022 to July 2024 using a semi-structured interview with 212 patients with primary headaches and complaints of sleep problems with a history of COVID-19 (main group, n=135 patients, 98% women, mean age 46.3 years) and without COVID-19 (control group, n=77, 54% women, mean age 45.7 years). COVID-19 was confirmed by a PCR test. Patients of both groups were included in the study in parallel according to the inclusion and exclusion criteria. The period from the onset of COVID-19 to the interview was ≥12 months in 57.7% of the patients, from 6 to 12 months in 20.1% of the patients, and up to 6 months in 22.2% of the patients. Most patients (87%) had mild symptoms of COVID-19. Results. Pre-existing sleep disorders (before the COVID-19 pandemic, before 2020) in patients with primary headaches were found in 56.3% of patients with a history of COVID-19 and 59.7% of patients without COVID-19. In 39 (28.8%) patients out of 135 patients with COVID-19, sleep disorders debuted for the first time at the onset of COVID-19 and persisted at the time of the interview (not less than 6 months): 25 patients (18.5%) had chronic insomnia, 5 patients (3.7%) restless legs syndrome, 7 people (5.2%) hypersomnia, 2 (1.5%) obstructive sleep apnea syndrome. In all these patients, sleep disturbances were not associated with anxiety, depression, other diseases, or medications, but were associated in close temporal relationship with COVID-19. Conclusion. Our study showed that a third of patients with primary headache disorders have new-onset sleep disorders associated with COVID-19 which persisted for a long time after recovery.
KW - COVID-19
KW - chronic insomnia
KW - headache
KW - hypersomnia
KW - obstructive sleep apnea syndrome
KW - post-COVID
KW - primary headaches sleep disorders
KW - restless legs syndrome
UR - https://www.mendeley.com/catalogue/b1b0c8e3-7d93-3549-b0a8-554f3633c046/
U2 - 10.17116/jnevro2025125081127
DO - 10.17116/jnevro2025125081127
M3 - статья
VL - 125
SP - 127
EP - 132
JO - ЖУРНАЛ НЕВРОЛОГИИ И ПСИХИАТРИИ ИМ. C.C. КОРСАКОВА
JF - ЖУРНАЛ НЕВРОЛОГИИ И ПСИХИАТРИИ ИМ. C.C. КОРСАКОВА
SN - 1997-7298
IS - 8
ER -
ID: 143573508